These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32062146)
1. Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment. Singh S; Ray LA; Shahi Thakuri P; Tran S; Konopka MC; Luker GD; Tavana H Biomaterials; 2020 Apr; 238():119853. PubMed ID: 32062146 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model. Singh S; Lamichhane A; Rafsanjani Nejad P; Heiss J; Baumann H; Gudneppanavar R; Leipzig ND; Konopka M; Luker GD; Tavana H Mol Cancer Res; 2022 Jul; 20(7):1166-1177. PubMed ID: 35348758 [TBL] [Abstract][Full Text] [Related]
3. Three-dimensional tumor model mimics stromal - breast cancer cells signaling. Ham SL; Thakuri PS; Plaster M; Li J; Luker KE; Luker GD; Tavana H Oncotarget; 2018 Jan; 9(1):249-267. PubMed ID: 29416611 [TBL] [Abstract][Full Text] [Related]
4. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992 [TBL] [Abstract][Full Text] [Related]
5. Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models. Sameni M; Tovar EA; Essenburg CJ; Chalasani A; Linklater ES; Borgman A; Cherba DM; Anbalagan A; Winn ME; Graveel CR; Sloane BF Clin Cancer Res; 2016 Feb; 22(4):923-34. PubMed ID: 26432786 [TBL] [Abstract][Full Text] [Related]
6. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A Front Immunol; 2019; 10():804. PubMed ID: 31105691 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion. Dang TT; Prechtl AM; Pearson GW Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556 [TBL] [Abstract][Full Text] [Related]
8. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment. Alcaraz LB; Mallavialle A; David T; Derocq D; Delolme F; Dieryckx C; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Du Manoir S; Huesgen PF; Overall CM; Tartare-Deckert S; Jacot W; Chardès T; Guiu S; Roger P; Reinheckel T; Moali C; Liaudet-Coopman E Theranostics; 2021; 11(13):6173-6192. PubMed ID: 33995652 [No Abstract] [Full Text] [Related]
9. CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/CXCR4 signaling axis in preclinical breast cancer model. Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Breast Cancer Cell Invasion Using an Organotypic Culture System. Ranftl RE; Calvo F Methods Mol Biol; 2017; 1612():199-212. PubMed ID: 28634945 [TBL] [Abstract][Full Text] [Related]
11. Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence. Lyes MA; Payne S; Ferrell P; Pizzo SV; Hollenbeck ST; Bachelder RE Breast Cancer Res Treat; 2019 Apr; 174(2):413-422. PubMed ID: 30594967 [TBL] [Abstract][Full Text] [Related]
12. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954 [TBL] [Abstract][Full Text] [Related]
14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Takai K; Le A; Weaver VM; Werb Z Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881 [TBL] [Abstract][Full Text] [Related]
16. Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression. Saini H; Nikkhah M Methods Mol Biol; 2021; 2258():241-255. PubMed ID: 33340365 [TBL] [Abstract][Full Text] [Related]
17. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells. Truong DD; Kratz A; Park JG; Barrientos ES; Saini H; Nguyen T; Pockaj B; Mouneimne G; LaBaer J; Nikkhah M Cancer Res; 2019 Jun; 79(12):3139-3151. PubMed ID: 30992322 [TBL] [Abstract][Full Text] [Related]
18. Phenanthroindolizidine Alkaloids Isolated from Reimche I; Yu H; Ariantari NP; Liu Z; Merkens K; Rotfuß S; Peter K; Jungwirth U; Bauer N; Kiefer F; Neudörfl JM; Schmalz HG; Proksch P; Teusch N Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142230 [TBL] [Abstract][Full Text] [Related]
19. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer. Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100 [TBL] [Abstract][Full Text] [Related]
20. Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors. Smeland HY; Lu N; Karlsen TV; Salvesen G; Reed RK; Stuhr L BMC Cancer; 2019 Mar; 19(1):234. PubMed ID: 30876468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]